Special Considerations in the Management of HIV-Infected Patients From Minority Communities

  • Authors: Bisola Ojikutu, MD, MPH; Valerie E. Stone, MD, MPH (More Info)
  • Section Editor: Judith S. Currier, MD, MSc
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 7/9/18 (What's New)

Summary

  • Blacks and Latinos represent approximately 70% of people with HIV/AIDS in the United States but are approximately 50% less likely to enroll in clinical trials than white patients[Gifford 2002]
    • Contributing Factors
    • Poor access to healthcare, low retention rates, distrust of the healthcare system, lack of knowledge of studies, and not being approached to enroll all contribute to lower participation rates in HIV clinical trials by minorities[Sengupta 2000; Castillo-Mancilla 2014]
    Overcoming Barriers to Participation
    • Improved communication and clinical trial education may encourage greater participation in clinical trials by minorities

Action required

Keywords: Minority-Ethnic Communities, Special Populations

©2020 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.